Status:
UNKNOWN
Insulin Resistance And End Stage Renal Disease: The Role Of Retinol Binding Protein 4
Lead Sponsor:
Fondazione IRCCS Policlinico San Matteo di Pavia
Conditions:
Insulin Resistance
Diabetes
Eligibility:
All Genders
18-70 years
Brief Summary
The purpose of this study is to determine whether Retinol binding protein 4 has a role in insulin resistance development in patients suffering from end stage renal disease on hemodialysis.
Eligibility Criteria
Inclusion
- Hemodialysis for "End Stage Renal Disease group"
- Normal Renal Function for "Control group"
Exclusion
- Diabetes
- Malnutrition
- Malignancy
- Acute Infection
- Chronic Active Infection
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00910130
Start Date
July 1 2008
Last Update
May 29 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Giovanni Piotti
Pavia, Italy, 27100